327 related articles for article (PubMed ID: 17936557)
1. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.
Guasch G; Schober M; Pasolli HA; Conn EB; Polak L; Fuchs E
Cancer Cell; 2007 Oct; 12(4):313-27. PubMed ID: 17936557
[TBL] [Abstract][Full Text] [Related]
2. Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.
Wakefield LM; Stuelten C
Cancer Cell; 2007 Oct; 12(4):293-5. PubMed ID: 17936552
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.
Bharathy S; Xie W; Yingling JM; Reiss M
Cancer Res; 2008 Mar; 68(6):1656-66. PubMed ID: 18339844
[TBL] [Abstract][Full Text] [Related]
4. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.
Achyut BR; Bader DA; Robles AI; Wangsa D; Harris CC; Ried T; Yang L
PLoS Genet; 2013; 9(2):e1003251. PubMed ID: 23408900
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.
Andl CD; McCowan KM; Allison GL; Rustgi AK
Neoplasia; 2010 Jun; 12(6):485-98. PubMed ID: 20563251
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris.
Doi H; Shibata MA; Kiyokane K; Otsuki Y
J Dermatol Sci; 2003 Oct; 33(1):7-16. PubMed ID: 14527734
[TBL] [Abstract][Full Text] [Related]
8. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
[TBL] [Abstract][Full Text] [Related]
10. Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.
Andl T; Le Bras GF; Richards NF; Allison GL; Loomans HA; Washington MK; Revetta F; Lee RK; Taylor C; Moses HL; Andl CD
Carcinogenesis; 2014 Nov; 35(11):2602-10. PubMed ID: 25233932
[TBL] [Abstract][Full Text] [Related]
11. Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing.
Denton CP; Khan K; Hoyles RK; Shiwen X; Leoni P; Chen Y; Eastwood M; Abraham DJ
J Invest Dermatol; 2009 Jan; 129(1):194-204. PubMed ID: 18563179
[TBL] [Abstract][Full Text] [Related]
12. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
Amendt C; Schirmacher P; Weber H; Blessing M
Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
[TBL] [Abstract][Full Text] [Related]
13. TGFβ signaling inhibits goblet cell differentiation via SPDEF in conjunctival epithelium.
McCauley HA; Liu CY; Attia AC; Wikenheiser-Brokamp KA; Zhang Y; Whitsett JA; Guasch G
Development; 2014 Dec; 141(23):4628-39. PubMed ID: 25377551
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
15. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
[TBL] [Abstract][Full Text] [Related]
17. Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src.
Alt-Holland A; Sowalsky AG; Szwec-Levin Y; Shamis Y; Hatch H; Feig LA; Garlick JA
J Invest Dermatol; 2011 Nov; 131(11):2306-15. PubMed ID: 21716326
[TBL] [Abstract][Full Text] [Related]
18. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
19. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL
Science; 2004 Feb; 303(5659):848-51. PubMed ID: 14764882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
